Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Arnaud Pouchon, Rayan Nasserdine, Clément Dondé, Antoine Bertrand, Mircea Polosan & Stéphanie Bioulac. (2023) A systematic review of pharmacotherapy for attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders. Expert Opinion on Pharmacotherapy 24:13, pages 1497-1509.
Read now
Read now
David B Clemow, Chris Bushe, Michele Mancini, Michael H Ossipov & Himanshu Upadhyaya. (2017) A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities. Neuropsychiatric Disease and Treatment 13, pages 357-371.
Read now
Read now
Paul Hammerness, Katherine McCarthy, Elizabeth Mancuso, Cassandra Gendron & Daniel Geller. (2009) Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review. Neuropsychiatric Disease and Treatment 5, pages 215-226.
Read now
Read now
Articles from other publishers (12)
Katrin Ruppert, Christoph Geffert, Hans-Willi Clement, Christian Bachmann, Michael Haberhausen, Eberhard Schulz, Christian Fleischhaker & Monica Biscaldi-Schäfer. (2022) Therapeutic drug monitoring of atomoxetine in children and adolescents with attention-deficit/ hyperactivity disorder: a naturalistic study. Journal of Neural Transmission 129:7, pages 945-959.
Crossref
Crossref
Nermin M. ShakerYara OsamaDoaa H. BarakatAhmed Adel AbdelgawadKarim Abdel AzizDina Aly El-Gabry. (2021) Atomoxetine in Attention-Deficit/Hyperactivity Disorder in Children With and Without Comorbid Mood Disorders. Journal of Child and Adolescent Psychopharmacology 31:5, pages 332-341.
Crossref
Crossref
Chi-Yung ShangHsien-Hsueh ShihYi-Lei PanHsiang-Yuan LinSusan Shur-Fen Gau. (2020) Comparative Efficacy of Methylphenidate and Atomoxetine on Social Adjustment in Youths with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology 30:3, pages 148-158.
Crossref
Crossref
Belén Rubio, Sergio Hernández, Oscar Herreros, Xavier Gastaminza, Rosario Cejas & Jennifer Castrillo. (2016) Efectividad cognitiva del metilfenidato y de la atomoxetina en el trastorno por déficit de atención con hiperactividad: una revisión. Revista de Psiquiatría Infanto-Juvenil 33:3, pages 367-377.
Crossref
Crossref
Victoria A. Reed, Jan K. Buitelaar, Ernie Anand, Kathleen Ann Day, Tamás Treuer, Himanshu P. Upadhyaya, David R. Coghill, Ludmila A. Kryzhanovskaya & Nicola C. Savill. (2016) The Safety of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Research. CNS Drugs 30:7, pages 603-628.
Crossref
Crossref
Nicola C. Savill, Jan K. Buitelaar, Ernie Anand, Kathleen Ann Day, Tamás Treuer, Himanshu P. Upadhyaya & David Coghill. (2015) The Efficacy of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Clinical Research. CNS Drugs 29:2, pages 131-151.
Crossref
Crossref
Chi-Yung ShangSusan Shur-Fen Gau. (2012) Improving Visual Memory, Attention, and School Function with Atomoxetine in Boys with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology 22:5, pages 353-363.
Crossref
Crossref
Aribert Rothenberger & Manfred Döpfner. (2011) Editorial: Observational studies in ADHD: the effects of switching to modified-release methylphenidate preparations on clinical outcomes and adherence. European Child & Adolescent Psychiatry 20:S2, pages 235-242.
Crossref
Crossref
J. Antoni Ramos-Quiroga & Miguel Casas. (2011) Achieving Remission as a Routine Goal of Pharmacotherapy in Attention-Deficit Hyperactivity Disorder. CNS Drugs 25:1, pages 17-36.
Crossref
Crossref
P Panei, R Arcieri, M Bonati, M Bugarini, A Didoni & E Germinario. (2010) Safety of psychotropic drug prescribed for attention-deficit/hyperactivity disorder in Italy. Adverse Drug Reaction Bulletin &NA;:260, pages 999-1002.
Crossref
Crossref
Paul Hammerness, Robert Doyle, Meghan Kotarski, Anna Georgiopoulos, Gagan Joshi, Sarah Zeitlin & Joseph Biederman. (2009) Atomoxetine in children with attention-deficit hyperactivity disorder with prior stimulant therapy: a prospective open-label study. European Child & Adolescent Psychiatry 18:8, pages 493-498.
Crossref
Crossref
David Coghill, Cesar Soutullo, Carlos d'Aubuisson, Ulrich Preuss, Trygve Lindback, Maria Silverberg & Jan Buitelaar. (2008) Impact of attention-deficit/hyperactivity disorder on the patient and family: results from a European survey. Child and Adolescent Psychiatry and Mental Health 2:1.
Crossref
Crossref